Position
TrinityBridge Ltd in Arcutis Biotherapeutics, Inc.
Back to the book · All holders of ARQT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$104$0.03 → $0.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 19K | $552 | — | — | — | 0.0% |
| Q1 2026 | 19K | $448 | $0.02 | −$104 | −$0 | 0.0% |